NL300114I1 - Klonering en expressie van gastheerbeschermende immunogen van IBDV. - Google Patents

Klonering en expressie van gastheerbeschermende immunogen van IBDV.

Info

Publication number
NL300114I1
NL300114I1 NL300114C NL300114C NL300114I1 NL 300114 I1 NL300114 I1 NL 300114I1 NL 300114 C NL300114 C NL 300114C NL 300114 C NL300114 C NL 300114C NL 300114 I1 NL300114 I1 NL 300114I1
Authority
NL
Netherlands
Prior art keywords
ibdv
immunogen
cloning
protecting
host
Prior art date
Application number
NL300114C
Other languages
English (en)
Other versions
NL300114I2 (nl
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Publication of NL300114I1 publication Critical patent/NL300114I1/nl
Publication of NL300114I2 publication Critical patent/NL300114I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL300114C 1985-05-30 2003-01-30 Klonering en expressie van gastheerbeschermende immunogen van IBDV. NL300114I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH081585 1985-05-30
AUPH211885 1985-08-23
PCT/AU1986/000156 WO1986007060A1 (en) 1985-05-30 1986-05-30 Cloning and expression of host-protective immunogens of ibdv

Publications (2)

Publication Number Publication Date
NL300114I1 true NL300114I1 (nl) 2003-04-01
NL300114I2 NL300114I2 (nl) 2003-10-01

Family

ID=25642952

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300114C NL300114I2 (nl) 1985-05-30 2003-01-30 Klonering en expressie van gastheerbeschermende immunogen van IBDV.

Country Status (7)

Country Link
US (2) US6054126A (nl)
EP (1) EP0222842B1 (nl)
JP (1) JP2988622B2 (nl)
CA (1) CA1334941C (nl)
DE (2) DE10399004I2 (nl)
NL (1) NL300114I2 (nl)
WO (1) WO1986007060A1 (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254463A (en) * 1981-09-18 1993-10-19 Genentech, Inc. Method for expression of bovine growth hormone
US5489529A (en) * 1984-07-19 1996-02-06 De Boer; Herman A. DNA for expression of bovine growth hormone
JPH03500601A (ja) * 1987-06-26 1991-02-14 コモンウェルス　サイエンティフィック　アンド　インダストリアル　リサーチ　オーガナイゼイション ウィルス中和及び保護モノクローナル抗体により認識されるｉｂｄｖ　ｖｐ２エピトープ
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form
US5632989A (en) * 1989-10-18 1997-05-27 University Of Maryland Attenuated, live vaccine for Delaware strain IBDV
WO1991016925A1 (en) * 1990-05-04 1991-11-14 University Of Maryland At College Park Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
WO2000012677A2 (en) * 1998-09-01 2000-03-09 The University Of Hong Kong Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
EP1296710A4 (en) * 2000-06-19 2004-05-12 Rahan Meristem RECOMBINANT VACCINES AGAINST INFECTIOUS BURSITY VIRUS
FR2824327B1 (fr) * 2001-05-02 2003-07-11 Agronomique Inst Nat Rech Particules pseudovirales de birnavirus
US6764684B2 (en) * 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
EP0198828A4 (en) * 1983-12-13 1986-11-04 Commw Scient Ind Res Org VACCINE AGAINST THE VIRUSES OF INFECTIOUS BURSAL DISEASE.
JPH03500601A (ja) * 1987-06-26 1991-02-14 コモンウェルス　サイエンティフィック　アンド　インダストリアル　リサーチ　オーガナイゼイション ウィルス中和及び保護モノクローナル抗体により認識されるｉｂｄｖ　ｖｐ２エピトープ
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
EP0222842A1 (en) 1987-05-27
DE10399004I2 (de) 2005-09-08
CA1334941C (en) 1995-03-28
JPH09316094A (ja) 1997-12-09
WO1986007060A1 (en) 1986-12-04
NL300114I2 (nl) 2003-10-01
JP2988622B2 (ja) 1999-12-13
US5849575A (en) 1998-12-15
DE10399004I1 (de) 2003-06-05
DE3650319D1 (de) 1995-06-14
EP0222842A4 (en) 1988-10-05
DE3650319T2 (de) 1996-01-25
EP0222842B1 (en) 1995-05-10
US6054126A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
NO167138C (no) Keramisk formdel og anvendelse av denne.
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO861606L (no) Kosmetisk antioksydant, samt fremstilling derav.
NL300114I1 (nl) Klonering en expressie van gastheerbeschermende immunogen van IBDV.
NO873325L (no) Sekresjon av heterologe proteiner av gjaer.
DK254488A (da) Azaindol- og indolizinderivater
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
NO870409D0 (no) Fremgangsmaate for spaltning av 1-aminoindaner.
FI853938A0 (fi) Anordning foer profilmaetning av raelshjul.
IT8521570A0 (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti.
DE3680771D1 (de) Isoxazolopyridophenoxazin- und isothiazolopyridophenoxazinderivate.
NO854968L (no) Alkosymetyleter- og alkoksymetylesterderivater.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
FI863657A (fi) Foerfarande foer framstaellning av n-sulfamyl-3-(2-guanidino-tiazol-4-yl-metyltio)-propionamidin.
NO872255D0 (no) Fremgangsmaate for dekaffinering av raakaffe.
FI864469A (fi) Anordning foer maetning av styvheten i paketaemnesveck.
NO863434L (no) Fremgangsmaate for fremstilling av metylendioksyfenantren- og stilbenderivater.
DE3680775D1 (de) Isoxazolopyridobenzoxazin- und isothiazolopyridobenzoxazinderivate.
ES1005896Y (es) Bigudi
FI863883A (fi) Anordning foer tillslutning av flaskhals.
FI852876A0 (fi) Anordning foer undervattensarbete.
TR22548A (tr) Sulfonilguanidinotriazin tuerevleri,hazirlanmalarina mahsus usuller ve herbisid olarak kullanilmalari
ES552000A0 (es) Procedimiento para preparar derivados de pirazol y bencimidazol.
NO872199D0 (no) Analogifremgangsmaate for fremstilling av alkoxyalkyl- og alkylmercaptoalkylsubstituerte benzofuroisokinoliner.
FI864790A (fi) Foerfarande foer framstaellning av 5-klor- och 5-brom-2-hydroxinikotinsyror.